APP
IMUC

Avantax Planning Partners’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Avantax Planning Partners’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-74
Closed – – 1482
2018
Q3 		$0 Buy
+74
New +$17 ﹤0.01% 1481
2018
Q2 		– Sell
-74
Closed – – 1895
2018
Q1 		$0 Buy
+74
New +$20 ﹤0.01% 1918

Other funds holding IMUC

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return